WO1997018207A3 - Novel macrocyclic compounds as metalloprotease inhibitors - Google Patents
Novel macrocyclic compounds as metalloprotease inhibitors Download PDFInfo
- Publication number
- WO1997018207A3 WO1997018207A3 PCT/US1996/018382 US9618382W WO9718207A3 WO 1997018207 A3 WO1997018207 A3 WO 1997018207A3 US 9618382 W US9618382 W US 9618382W WO 9718207 A3 WO9718207 A3 WO 9718207A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- macrocyclic compounds
- metalloprotease inhibitors
- inhibitors
- novel macrocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96943497A EP0863885A2 (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
EE9800115A EE9800115A (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
EA199800372A EA199800372A1 (en) | 1995-11-14 | 1996-11-13 | NEW MICROCYCLIC COMPOUNDS INHIBITORS |
SI9620120A SI9620120A (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
KR1019980703618A KR19990067592A (en) | 1995-11-14 | 1996-11-13 | Novel Macrocyclic Compound as Metalloprotease Inhibitor |
JP9519119A JP2000502050A (en) | 1995-11-14 | 1996-11-13 | New macrocyclic compounds as metalloprotease inhibitors |
SK634-98A SK63498A3 (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
IL12436696A IL124366A0 (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
BR9611563A BR9611563A (en) | 1995-11-14 | 1996-11-13 | Compound pharmaceutical composition method of treating an inflammatory disease and assay to detect agrecanase inhibitors |
AU12726/97A AU1272697A (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
NO982185A NO982185L (en) | 1995-11-14 | 1998-05-13 | Novel macrocyclic compounds as metalloproteinase inhibitors |
LVP-98-104A LV12167B (en) | 1995-11-14 | 1998-07-07 | Novel macrocyclic compounds as metalloprotease inhibitors |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US668495P | 1995-11-14 | 1995-11-14 | |
US60/006,684 | 1995-11-14 | ||
US64690296A | 1996-05-08 | 1996-05-08 | |
US60/646,902 | 1996-05-08 | ||
US74343996A | 1996-11-01 | 1996-11-01 | |
US08/743,439 | 1996-11-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997018207A2 WO1997018207A2 (en) | 1997-05-22 |
WO1997018207A3 true WO1997018207A3 (en) | 1997-07-24 |
Family
ID=27358171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/018382 WO1997018207A2 (en) | 1995-11-14 | 1996-11-13 | Novel macrocyclic compounds as metalloprotease inhibitors |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0863885A2 (en) |
JP (1) | JP2000502050A (en) |
CN (1) | CN1202161A (en) |
BR (1) | BR9611563A (en) |
CA (1) | CA2237524A1 (en) |
CZ (1) | CZ144798A3 (en) |
EE (1) | EE9800115A (en) |
HR (1) | HRP960533A2 (en) |
HU (1) | HUP0201479A2 (en) |
IL (1) | IL124366A0 (en) |
LV (1) | LV12167B (en) |
MX (1) | MX9803851A (en) |
NO (1) | NO982185L (en) |
PL (1) | PL326714A1 (en) |
SI (1) | SI9620120A (en) |
SK (1) | SK63498A3 (en) |
WO (1) | WO1997018207A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281352B1 (en) | 1995-11-14 | 2001-08-28 | Dupont Pharmaceuticals Company | Macrocyclic compounds as metalloprotease inhibitors |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9820B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | Macrocyclic inhibitors of matrix metalloproteinases and tnf x secretion |
US6548663B1 (en) | 1998-03-31 | 2003-04-15 | Bristol-Myers Squibb Pharma Company | Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
JP4487019B2 (en) | 1998-03-31 | 2010-06-23 | ランサス メディカル イメージング インコーポレイテッド | Drugs for imaging angiogenic diseases |
US6524553B2 (en) | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
WO1999064406A1 (en) | 1998-06-11 | 1999-12-16 | Du Pont Pharmaceuticals Company | A process for the preparation of macrocyclic metalloprotease inhibitors |
NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
AU766822B2 (en) | 1998-12-18 | 2003-10-23 | Du Pont Pharmaceuticals Company | Vitronectin receptor antagonist pharmaceuticals |
US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
WO2000035887A2 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharm Co | Vitronectin receptor antagonist pharmaceuticals |
US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6649377B1 (en) | 1999-05-10 | 2003-11-18 | Syntex (U.S.A.) Llc | Human aggrecanase and nucleic acid compositions encoding the same |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
US6989139B2 (en) * | 2000-02-15 | 2006-01-24 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
WO2001092235A1 (en) | 2000-06-01 | 2001-12-06 | Bristol-Myers Squibb Pharma Company | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
PT2087908T (en) | 2001-06-26 | 2018-07-16 | Amgen Inc | Antibodies to opgl |
PE20030701A1 (en) | 2001-12-20 | 2003-08-21 | Schering Corp | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
US7491794B2 (en) | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
JPWO2005044780A1 (en) * | 2003-11-10 | 2007-05-17 | 杏林製薬株式会社 | Aminocarboxylic acid derivatives and their addition salts and S1P receptor modulators |
CA2708281A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
US8476305B2 (en) | 2008-02-07 | 2013-07-02 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient |
WO2010132494A1 (en) * | 2009-05-11 | 2010-11-18 | Ghosh Arun K | Compounds and methods for treating aids and hiv infections |
WO2012156756A2 (en) | 2011-05-19 | 2012-11-22 | Centro Nacional De Investigaciones Oncológicas (Cnio) | New compounds |
CN102276546B (en) * | 2011-05-31 | 2014-06-25 | 中国科学院广州生物医药与健康研究院 | Compound used as aggrecanase modifier and application thereof |
CN108727293B (en) * | 2016-09-18 | 2021-05-11 | 广西师范大学 | 1,2, 8-oxo diazacyclononane-9-one derivative and synthetic method thereof |
AU2019352741A1 (en) | 2018-10-04 | 2021-05-06 | Assistance Publique-Hôpitaux De Paris (Aphp) | EGFR inhibitors for treating keratodermas |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992013831A1 (en) * | 1991-02-07 | 1992-08-20 | British Bio-Technology Limited | Hydroxamic acid derivatives, process for their preparation and use thereof |
US5427954A (en) * | 1992-04-29 | 1995-06-27 | Shriner's Hospitals For Crippled Children | Compositions and methods for detection and treatment of human osteoarthritis |
-
1996
- 1996-11-13 EE EE9800115A patent/EE9800115A/en unknown
- 1996-11-13 IL IL12436696A patent/IL124366A0/en unknown
- 1996-11-13 CN CN96198327A patent/CN1202161A/en active Pending
- 1996-11-13 HU HU0201479A patent/HUP0201479A2/en unknown
- 1996-11-13 SI SI9620120A patent/SI9620120A/en unknown
- 1996-11-13 HR HR08/743,439A patent/HRP960533A2/en not_active Application Discontinuation
- 1996-11-13 JP JP9519119A patent/JP2000502050A/en active Pending
- 1996-11-13 CA CA002237524A patent/CA2237524A1/en not_active Abandoned
- 1996-11-13 PL PL96326714A patent/PL326714A1/en unknown
- 1996-11-13 BR BR9611563A patent/BR9611563A/en not_active IP Right Cessation
- 1996-11-13 SK SK634-98A patent/SK63498A3/en unknown
- 1996-11-13 EP EP96943497A patent/EP0863885A2/en not_active Withdrawn
- 1996-11-13 CZ CZ981447A patent/CZ144798A3/en unknown
- 1996-11-13 WO PCT/US1996/018382 patent/WO1997018207A2/en not_active Application Discontinuation
-
1998
- 1998-05-13 NO NO982185A patent/NO982185L/en unknown
- 1998-05-14 MX MX9803851A patent/MX9803851A/en unknown
- 1998-07-07 LV LVP-98-104A patent/LV12167B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992013831A1 (en) * | 1991-02-07 | 1992-08-20 | British Bio-Technology Limited | Hydroxamic acid derivatives, process for their preparation and use thereof |
US5427954A (en) * | 1992-04-29 | 1995-06-27 | Shriner's Hospitals For Crippled Children | Compositions and methods for detection and treatment of human osteoarthritis |
Non-Patent Citations (5)
Also Published As
Publication number | Publication date |
---|---|
EE9800115A (en) | 1998-10-15 |
CA2237524A1 (en) | 1997-05-22 |
NO982185L (en) | 1998-07-13 |
JP2000502050A (en) | 2000-02-22 |
LV12167A (en) | 1998-11-20 |
PL326714A1 (en) | 1998-10-26 |
CN1202161A (en) | 1998-12-16 |
LV12167B (en) | 1999-03-20 |
HUP0201479A2 (en) | 2002-08-28 |
EP0863885A2 (en) | 1998-09-16 |
MX9803851A (en) | 1998-09-30 |
SI9620120A (en) | 1999-06-30 |
IL124366A0 (en) | 1998-12-06 |
SK63498A3 (en) | 1999-01-11 |
BR9611563A (en) | 1999-03-02 |
WO1997018207A2 (en) | 1997-05-22 |
CZ144798A3 (en) | 1998-10-14 |
HRP960533A2 (en) | 1998-04-30 |
NO982185D0 (en) | 1998-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997018207A3 (en) | Novel macrocyclic compounds as metalloprotease inhibitors | |
WO1999009000A3 (en) | Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis | |
UA48939C2 (en) | Disubstituted furanons, methods for synthesis, pharmaceutical composition, method for treating inflammatory disease, intermediate substances | |
WO2000055139A3 (en) | Heterocyclic urea and related compounds useful as anti-inflammatory agents | |
WO2001042231A3 (en) | Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors | |
PT1465626E (en) | Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses | |
WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
WO2003044021A3 (en) | Substituted indolizine-like compounds and methods of use | |
LU91145I9 (en) | ||
WO2002012242A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
MXPA02010618A (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta. | |
WO2004062625A3 (en) | Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease | |
WO2002096361A3 (en) | 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors | |
WO2005065195A3 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2002040702A3 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
WO2005018545A3 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
CA2234642A1 (en) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors | |
AU7385398A (en) | Novel macrocyclic compounds as metalloprotease inhibitors | |
WO2002007669A3 (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
DE60008540D1 (en) | AROMATIC ESTERS OF CAMPTOTHECINES AND METHOD FOR TREATING CANCER DISEASES | |
EP1812007A4 (en) | Pyridazine compounds and methods | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
PL328225A1 (en) | Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors | |
DE69715173D1 (en) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
WO2001083450A3 (en) | (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96198327.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AM AU AZ BR BY CA CN CZ EE HU IL JP KG KR KZ LT LV MD MX NO NZ PL RO RU SG SI SK TJ TM UA VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT.BUL.22/97 UNDER INID (30) "PRIORITY DATA", REPLACE "NOT FURNISHED" BY "08/743439" |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WR | Later publication of a revised version of an international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996943497 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 98-00941 Country of ref document: RO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 324933 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-1447 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 2237524 Country of ref document: CA Ref document number: 2237524 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1997 519119 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 63498 Country of ref document: SK Ref document number: 199800372 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 98-068 Country of ref document: LT Ref document number: 1019980703618 Country of ref document: KR Ref document number: PA/a/1998/003851 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1199800505 Country of ref document: VN |
|
ENP | Entry into the national phase |
Ref document number: 1998 980104 Country of ref document: LV Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998980104 Country of ref document: LV |
|
WWP | Wipo information: published in national office |
Ref document number: 1996943497 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-1447 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 98-068 Country of ref document: LT |
|
WWR | Wipo information: refused in national office |
Ref document number: 98-068 Country of ref document: LT |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980703618 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1998-1447 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019980703618 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996943497 Country of ref document: EP |